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TLR	 Localisation	 Adaptors	used	 Main	PAMPs	 PAMP	origin	
TLR2-1	heterodimer	 Cell	surface	 MAL,	MyD88	 Triacyl	lipoprotein	 Bacteria	
TLR2-6	heterodimer	 Cell	surface	 MAL,	MyD88	 Diacyl	lipoprotein	 Bacteria	




TLR5	 Cell	surface	 MyD88	 Flagellin	 Bacteria	
TLR7	 Endosome	 MyD88	 ssRNA	 Bacteria,	viruses,	
fungi	
TLR8	 Endosome	 MyD88	 ssRNA	 Viruses	
TLR9	 Endosome	 MyD88	 DNA	 Bacteria,	viruses,	
fungi	

































































































































Species	 Protein	 Protein	ID	 Amino	acids	
Homo	Sapiens	 TLR1	 CAG38593.1	 639-775	
Homo	Sapiens	 TLR2	 AAH33756	 643-784	
Homo	Sapiens	 TLR3	 AAH59372	 758-862	
Homo	Sapiens	 TLR4	 AAY82270	 676-814	
Homo	Sapiens	 TLR5	 AAI09119	 695-832	
Homo	Sapiens	 TLR6	 BAA78631	 644-780	
Homo	Sapiens	 TLR7	 AAQ88659	 893-1034	
Homo	Sapiens	 TLR8	 AAQ88663	 882-1020	
Homo	Sapiens	 TLR9	 AAQ89443	 872-1009	
Homo	Sapiens	 TLR10	 AAQ88667	 636-774	
Homo	Sapiens	 MyD88	 NP_002459	 176-305	
Homo	Sapiens	 MAL	 NP_001034750	 86-168	
Homo	Sapiens	 TRIF	 BAC44839	 395-527	
Homo	Sapiens	 TRAM	 AAO74498	 81-174	
Homo	Sapiens	 SARM	 NP_055892	 561-700	
Homo	Sapiens	 SIGIRR	 CAG33619	 167-304	
Dictyostelium	discoideum	 TirA	 XP_636358	 821-915	
Caenorhabditis	elegans	 Tir-1	 NP_001021253	 578-718	
Yersinia	pestis	 YpTdp	 WP_002213208	 139-240	
Brucella	melitensis	 TcpB	 AAL52855	 121-233	
Bacillus	anthracis	 BaTdp	 WP_000291405	 128-255	







































































Tag	 Size	 Main	purpose	 Basis	for	detection	
His	 0.8	kDa	 Purification,	detection	 Antibody	
GST	 26	kDa	 Purification,	detection,	stability,	expression	yield	 Antibody	
GB1	 6	kDa	 Stability,	expression	yield	 N/A	
GFP	 27	kDa	 Detection	 Fluorescence,	antibody	
FLAG	 1	kDa	 Detection	 Antibody	
































































































































































































Protein	 Culture	media	 Purification	steps	 Yield	(mg/L)	
His-SARM-TIR	 TB	 IMAC,	IEXC	 0.2	
His-SARM-ST	 TB	 IMAC,	IEXC	 0.2	
GST-SARM-TIR	 TB	 Affinity	 2	
GST-SARM-ST	 TB	 Affinity	 2	
GB1-SARM-TIR	 LB	 IMAC	 2	
GB1-MyD88-TIR	 LB	 IMAC,	SEC	 2	
GST-MyD88-TIR	 LB	 Affinity	 1	
GST-TRIF-TIR	 LB	 Affinity	 1	
GST-MAL	 LB	 Affinity	 1	
GST-TRAM	 LB	 Affinity,	IEXC	 1	
GB1-YpTIR	 LB	 IMAC	 5	


























































































































































































































































































































































Construct	 Residues	 Nucleotide	sequence	(5’-3’)	 Vector	
GFP-BaTdp	 1-273	 GATCAAGCTTCGATGTATTATCATATTAG	
GATCGGTACCTTAATACGTAACTTTTAATCC	
pEGFP-C1	
BaTdp-FLAG	 1-273	 GATCAAGCTTATGTATTATCATATTAGAATTAA	
GATCGGTACCTTAATACGTAACTTTTAATCC		
pXJ40-FLAG	Underlined	sequences,	AAGCTT	and	GGTACC,	correspond	to	restriction	sites	HindIII	and	KpnI,	respectively.		
6.2.3	Measurement	of	autophagy		 The	protocol	for	measuring	autophagy	in	cells	was	adapted	from	(Harris	et	al.,	2009).	HEK293	cells	were	seeded	in	6-well	plates	at	5	x	105	cells	per	well	24	hours	before	transfection.	At	24	or	48	hours	post-transfection,	cells	were	washed	in	PBS	and	then	harvested	and	lysed	in	PBS	with	1%	SDS	at	RT	for	30	min	under	mild	agitation,	followed	by	boiling	at	95°C	for	10	min.	The	lysate	was	then	mixed	1:1	with	2X	SDS	loading	buffer,	further	boiled	at	95°C	for	5	min,	and	analysed	by	Western	blot	using	a	rabbit	polyclonal	α-LC3B	antibody.	Autophagy	was	followed	through	the	conversion	of	cytosolic	LC3-I	to	LC3-II,	the	latter	running	slightly	faster	during	separation	by	SDS-PAGE.	Cells	were	incubated	at	
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37°C	for	up	to	4	hours,	after	which	they	were	washed	twice	in	chilled	PBS,	and	analysed	for	LC3-II	content	by	Western	blot	as	described	above.		
6.3	Results	
6.3.1	BaTdp	co-localises	with	tubular	networks		 From	chapter	5,	we	observed	that	both	SARM	and	MyD88	appear	to	localise	to	cellular	mitochondria	when	expressed	in	mammalian	cells,	so	we	speculated	that	BaTdp	might	do	the	same.	To	study	the	cellular	localisation	of	BaTdp	expressed	in	mammalian	cells,	HEK	cells	grown	on	coverslips	in	12-well	plates	were	transfected	with	1	µg	pEGFP-BaTdp	and	pXJ40-FLAG-MyD88	using	Turbofect	reagent.	24	hours	post	transfection,	cells	were	washed	and	stained	with	mitotracker	dye,	followed	by	fixation	with	4%	PFA	and	mounting	on	microscopy	slides	in	DAPI-containing	mounting	medium.	As	shown	in	Figure	
6.1,	no	obvious	mitochondrial	localisation	was	observed	when	cells	were	viewed	under	fluorescence	microscope.		
	
Figure	6.1	BaTdp,	unlike	SARM,	does	not	localise	to	mitochondria.	HEK-TLR4	cells	were	co-transfected	with	plasmids	encoding	GFP-tagged	BaTdp	or	FLAG-tagged	MyD88.	After	24	h,	cells	were	treated	with	mitotracker	dye	to	stain	mitochondria	and	DAPI	to	stain	cell	nuclei,	followed	by	visualisation	using	fluorescence	microscopy.	All	scale	bars,	10	µm.	Original	magnification	X100.		 	
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The	protein	did	not	localise	in	a	similar	pattern	to	either	SARM	or	MyD88,	but	rather	it	localised	into	a	discrete	cytosolic	network	forming	patterns,	particularly	near	the	cell	membrane.	In	a	study	on	the	Brucella	encoded	Tdp	TcpB	by	Radhakrishnan	and	colleagues,	TcpB	was	found	to	co-localise	with	both	microtubules	and	the	plasma	membrane	(Radhakrishnan	et	al.,	2009),	prompting	us	to	investigate	whether	BaTdp	was	doing	the	same	here.	Microscopy	analysis	of	HEK-TLR4	cells	expressing	GFP-BaTdp	that	were	stained	with	α-β	tubulin	and	fluorescent	secondary	antibody	(Fig.	6.2)	revealed	a	clear	overlap	of	BaTdp	and	tubulin,	suggesting	that	BaTdp	targets	cytoskeletal	networks	when	expressed	in	mammalian	cells.	Radhakrishnan	and	colleagues	reported	a	noticeable	shrinkage	and	rounding	of	cells	following	TcpB	expression	in	HEK-cells	(Radhakrishnan	et	al.,	2009),	suggesting	a	cytotoxic	effect,	but	we	did	not	see	such	similar	morphological	changes	in	HEK	cells	following	BaTdp	expression.	
	
Figure	6.2	BaTdp	co-localise	with	tubulin.	HEK-TLR4	cells	were	transfected	with	plasmid	encoding	GFP-tagged	BaTdp.	After	24	h,	cells	were	stained	with	α-β	tubulin	antibody,	followed	by	secondary	staining	with	α-rabbit	IgG	Alexa	Fluor	568	conjugate	secondary	antibody	and	treatment	with	DAPI	to	stain	cell	nuclei.	Figure	shows	two	representative	cells.	All	scale	bars,	10	µm.	Original	magnification	X100.			
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6.3.2	BaTdp	expression	results	in	mild	reduction	of	cell	viability		 The	overall	cell	viability	of	HEK	cells,	expressing	BaTdp,	was	determined	by	MTT	cell	viability	assay.	Cells	were	grown	in	96-well	plates	and	transfected	with	increasing	amounts	of	pCDNA-BaTdp,	pCDNA-BaTdp	(G164A)	or	empty	pCDNA	vector	as	control	and	treated	with	MTT	reagent	for	four	hours	at	indicated	time	points,	followed	by	dissolving	the	formazan	crystals	in	10%	SDS,	10	mM	HCl	over	night.	Cell	viability	was	quantitated	by	reading	the	absorbance	at	590	nm	using	a	microplate	reader.	As	shown	in	Figure	6.3,	the	expression	of	BaTdp	was	associated	with	a	slight	but	not	significant	decrease	of	viable	cells,	compared	to	control	cells.			
	
Figure	6.3	MTT	cell	viability	assay	of	HEK293T	cells	expressing	BaTdp	or	BaTdp	
(G164A).	HEK293T	cells	were	transfected	with	plasmids	coding	for	either	WT	BaTdp	(A)	or	BaTdp	(G164A)	(B)	and	treated	with	MTT	dye	to	quantify	overall	cell	viability.	Formazan	crystals	were	solubilised	overnight	and	the	cell	viability	was	assessed	by	measuring	absorbance	at	590	nm.	Data	represent	the	means	±	SD	of	three	independent	experiments.		
6.3.3	BaTdp	expression	does	not	induce	cellular	apoptosis		 We	also	wanted	to	test	whether	BaTdp	expression	would	induce	apoptosis	in	mammalian	cells,	as	previously	shown	with	SARM	expression	in	chapter	5.	HEK293T	cells	were	transfected	with	pCDNA	vectors	coding	for	either	
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WT	BaTdp	or	G164A	mutant	protein,	as	well	as	empty	vector	as	a	negative	control.	As	shown	in	Figure	6.4,	there	was	no	indication	of	BaTdp	expression	being	associated	with	a	change	in	apoptotic	marker	Annexin	V,	suggesting	that	the	protein	is	not	pro-apoptotic.		
	
Figure	6.4	BaTdp	expression	does	not	induce	cellular	apoptosis.	HEK293T	cells	were	transfected	with	pCDNA-BaTdp	or	pCDNA-BaTdp	(G164A)	plasmids	and	double-stained	with	Annexin	V	and	7-AAD	24	or	48	hours	post	transfection,	followed	by	FACS	analysis	(A).	Dot	plots	are	representative	of	three	independent	experiments.	(B)	Statistical	analysis	of	three	independent	experiments.	Data	represent	the	means	±	SD.	NT,	non-transfected;	EV,	empty	vector.		
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6.3.4	BaTdp	expression	did	not	inhibit	LPS-mediated	cytokine	
activation	in	HEK-TLR4	cells		 As	shown	in	chapter	4,	the	BaTdp	TIR	domain	specifically	interacted	with	multiple	TLR	adaptor	proteins	in	vitro,	including	the	key	adaptor	MyD88.	This	may	be	an	indication	that	BaTdp	expression	in	mammalian	cells	would	disrupt	TLR-mediated	signalling.	To	evaluate	whether	BaTdp	expression	had	any	effect	on	the	activation	of	inflammatory	cytokines	in	HEK-TLR4	cells	following	LPS	stimulation,	cells	were	seeded	in	24-well	plates	and	transfected	with	various	amounts	of	pCDNA-BaTdp.	24	hours	post	transfection,	cells	were	stimulated	with	100	ng/mL	LPS	for	an	additional	24	hours,	followed	by	quantification	of	IL-8	and	TNFα	in	the	cell	supernatants	by	ELISA.	IL-6	content	was	also	quantified,	but	the	concentrations	were	below	the	detection	limit	in	all	samples	(data	not	shown).		 As	shown	in	Figure	6.5,	BaTdp	expression	had	no	apparent	effect	on	cellular	secretion	of	IL-8	or	TNFα.	This	is	in	contrast	to	SARM	expression,	which	efficiently	suppressed	LPS-mediated	activation	of	both	IL-8	and	TNFα,	and	further	suggests	that	unlike	SARM,	BaTdp	may	not	have	an	anti-inflammatory	effect	on	host	cells.	Furthermore,	the	G164A	mutation	in	the	predicted	BaTdp	BB-loop	region	did	not	affect	the	result	in	any	way.		
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Figure	6.5	BaTdp	expression	has	no	effect	on	LPS-mediated	TNFα	and	IL-8	
secretion	in	HEK-TLR4	cells.	HEK-TLR4	cells	were	transfected	with	increasing	amounts	of	pCDNA-BaTdp	(A)	or	pCDNA-BaTdp	(G164A)	(B)	plasmid.	24	hours	post	transfection,	cells	were	stimulated	with	100	ng/mL	LPS	for	an	additional	24	hours.	Cell	supernatants	were	collected	and	analysed	for	IL-8	and	TNFα	content.	Data	represent	means	±	SD	of	at	least	three	independent	experiments.			 From	the	results	shown	above,	it	would	appear	that	BaTdp	does	not	affect	TLR-mediated	immune	activation,	but	the	lack	of	effect	may	have	been	due	to	the	choice	of	receptor	used	for	immune	activation.	The	reason	for	using	HEK-TLR4	as	a	model	cell	line	is	that	TLR4	is	the	only	human	TLR	known	to	utilise	both	MyD88-	and	TRIF-mediated	signalling.	However,	the	PAMP	it	recognises	is	LPS,	which	B.	anthracis,	a	Gram-positive	bacterium,	does	not	express.	As	mentioned	in	section	1.4.7,	TLR4	also	recognises	anthrolysin	O,	expressed	by	B.	anthracis,	but	this	may	be	a	minor	mechanism	for	pathogen	detection	in	this	case.	To	ensure	
	 197	
that	the	inability	for	BaTdp	to	reduce	host	cell	secretion	of	inflammatory	cytokines	was	not	a	receptor-specific	effect,	we	further	decided	to	conduct	a	similar	experiment	using	HEK-TLR2	cells.		
6.3.5	BaTdp	expression	has	no	effect	on	cytokine	secretion	in	
HEK-TLR2	cells		 LTA	expressed	on	cellular	membranes	of	Gram-positive	bacteria	such	as	
B.	anthracis	is	one	of	the	main	PAMPs	recognised	by	TLR2,	which	makes	HEK-TLR2	a	well-suited	cell	line	to	study	any	suppressive	effect	BaTdp	may	have	on	TLR	mediated	immune	activation.	Although	this	receptor	only	signals	via	the	MyD88	dependent	pathway,	our	data	indicate	that	the	BaTdp	TIR	domain	interacts	specifically	with	MyD88-TIR	(section	4.3.3),	which	may	constitute	a	mechanism	of	action.		 HEK-TLR2	cells	were	grown	in	24-well	plates	and	transfected	with	increasing	amounts	of	plasmid	encoding	for	BaTdp,	as	well	as	G164A	mutant	protein,	and	incubated	for	24	hours	followed	by	stimulation	with	1000	ng/mL	LTA	for	an	additional	24	hours.	Secreted	amounts	of	IL-8	in	culture	supernatants	were	then	analysed	by	ELISA	(Fig.	6.6).	TNFα	levels	were	also	analysed,	but	results	suggested	that	the	content	was	below	the	detection	limit	(data	not	shown).		
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Figure	6.6	BaTdp	expression	has	no	effect	on	LTA-mediated	IL-8	secretion	in	HEK-
TLR2	cells.	HEK-TLR2	cells	were	transfected	with	increasing	amounts	of	pCDNA-BaTdp	(A)	or	pCDNA-BaTdp	(G164A)	(B)	plasmid.	24	hours	post-transfection,	cells	were	stimulated	with	1000	ng/mL	LTA	for	an	additional	24	hours.	Cell	supernatants	were	collected	and	analysed	for	IL-8	content.	Data	represent	means	±	SD	of	at	least	three	independent	experiments.			 Consistent	with	the	results	from	experiments	conducted	in	HEK-TLR4	cells,	BaTdp	expression	had	no	significant	effect	on	LTA	induced	IL-8	activation	in	HEK-TLR2	cells,	further	indicating	that	the	BaTdp	protein	may	not	have	an	immune	suppressive	function	when	expressed	in	mammalian	cells.	The	results	suggest	that	unlike	many	other	bacterial	Tdps,	BaTdp	does	not	have	an	anti-inflammatory	effect	on	host	cells,	leading	us	to	speculate	on	what	its	actual	function	is.		
6.3.6	BaTdp	expression	induces	autophagy	in	HEK293T	cells		 Given	that	BaTdp	appeared	to	localise	to	tubular	networks	when	expressed	in	mammalian	cells,	we	suspected	that	the	protein	may	act	on	autophagy-related	pathways.	This	is	one	of	the	main	internal	housekeeping	systems	for	maintaining	cellular	homeostasis	by	removing	unwanted	cytosolic	components	(Eskelinen,	2005),	and	tubulin	is	known	to	play	an	important	role	in	
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autophagosome	formation	in	mammalian	cells	(Geeraert	et	al.,	2010).	As	mentioned	in	chapter	1,	the	process	involves	the	generation	of	autophagosomes	surrounding	the	target	molecules,	which	then	fuse	with	a	lysosome	to	initiate	degradation	via	hydrolytic	enzymes.	A	key	marker	for	this	process	is	the	lipidation	of	cytosolic	LC3	(LC3-I)	to	form	LC3-II	(Kabeya	et	al.,	2000),	which	enables	the	protein	to	localise	to	the	autophagosome	and	autolysosome.	Monitoring	the	lipidation	of	LC3-I	by	Western	blot	analysis	is	an	established	method	for	detecting	cellular	autophagy	and	has	previously	been	used	successfully	with	HEK	cells	(Tanida	et	al.,	2005,	Tanida	et	al.,	2008).		To	test	whether	BaTdp	expression	in	mammalian	cells	was	associated	with	increased	autophagy	activity,	HEK293T	cells	were	transfected	with	pCDNA-BaTdp	plasmids.	24	or	48	hours	post-transfection,	cell	lysates	were	resolved	by	SDS-PAGE	and	analysed	for	LC3-content	by	Western	blot.	LC3-II	is	a	highly	hydrophobic	protein	that	is	only	partially	soluble	in	standard	lysis	buffers	(Tanida	et	al.,	2008),	so	1%	SDS	in	PBS	buffer	was	used	here	in	order	to	fully	extract	the	cellular	protein	content.	As	shown	in	Figure	6.7,	a	significant	increase	in	LC3-II	could	be	seen	in	cells	expressing	BaTdp	48	hours	post	transfection,	indicating	an	increase	in	autophagy.	The	G164A	mutation	was	associated	with	a	reduction	of	this	effect,	suggesting	that	this	residue	is	functionally	important.	However,	given	that	the	primary	antibody	used	for	detection	recognises	both	LC3-I	and	LC3-II,	we	were	surprised	to	see	that	the	amount	of	LC3-I	detected	by	Western	blot	analysis	was	very	low.			
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Figure	6.7	BaTdp	expression	induces	cellular	autophagy	in	HEK293T	cells.	(A)	HEK293T	cells	were	transfected	with	plasmid	encoding	for	either	WT	BaTdp	or	BaTdp	(G164A).	After	24	or	48	hours,	cells	were	lysed	in	PBS	containing	1%	SDS	followed	by	assessment	of	LC3B	content	by	Western	blot	analysis.	(B)	Immunoblots	were	analysed	by	densitometry	using	ImageJ	software	(Schneider	et	al.,	2012).	For	each	sample,	the	LC3B-II	value	was	normalised	against	the	corresponding	GAPDH	value.	Error	bars,	SD	of	triplicates.	*p	<	0.05.			 HEK293T	cells	expressing	GFP-tagged	BaTdp	were	also	immunostained	with	α-LC3B	antibody,	followed	by	secondary	staining	with	α-rabbit	IgG	Alexa	Fluor	568	conjugate	to	observe	LC3	content	of	cells	via	fluorescence	microscopy	(Fig.	6.8).	An	accumulation	of	LC3	could	be	seen	in	cells	expressing	GFP-BaTdp,	while	cells	expressing	free	GFP	or	transfected	with	empty	plasmid	control	displayed	nearly	undetectable	levels	of	LC3.	
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Figure	6.8	Accumulation	of	LC3	in	HEK293T	cells	expressing	GFP-BaTdp.	HEK293T	cells	were	transfected	with	plasmids	encoding	GFP-tagged	BaTdp	or	free	GFP	for	48	hours,	followed	by	immunostaining	with	α-LC3B	and	α-rabbit	IgG	Alexa	Fluor	568	conjugate	antibody	and	analysis	by	fluorescence	microscopy.	Cell	nuclei	were	stained	with	DAPI.	All	scale	bars,	10	µm.	Original	magnification	X100.	NT,	non-transfected	cell.		
6.4	Discussion		 From	the	results	presented	in	this	chapter,	it	is	clear	that	BaTdp	operates	in	a	distinctly	different	manner	compared	to	SARM.	Bacterial	Tdps	have	been	discovered	in	a	vast	number	of	species,	and	several	studies	have	confirmed	that	some	of	these	are	able	to	regulate	host	TLR-signalling	(Rana	et	al.,	2013).	However,	the	presence	of	Tdps	in	non-pathogenic	bacteria	suggests	that	these	proteins	may	also	have	other	functions.	Recently,	a	study	by	Patterson	and	colleagues	indicated	that	two	TIR-like	proteins	from	S.	aureus	(SaTlp1	and	SaTlp2)	do	not	inhibit	TLR	signalling,	but	rather	upregulate	host	immune	signalling	through	NFκB	activation	(Patterson	et	al.,	2014).	Askarian	and	colleagues	had	previously	been	able	to	demonstrate	that	another	S.	aureus	Tdp	(TirS)	was	able	to	inhibit	TLR2-mediated	NFκB	activation	in	vitro	(Askarian	et	
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al.,	2014).	It	seems	clear	that	bacterial	Tdps	do	not	possess	a	single	unified	function,	but	are	able	to	interact	with	various	different	host	mechanisms	for	different	purposes.		In	addition	to	the	data	presented	here,	our	collaborators	at	the	Defence	DSTL	performed	in	vivo	experiments	with	a	B.	anthracis	BaTdp	KO	strain.	No	significant	difference	in	the	median	lethal	dose	(MLD)	could	be	seen	between	the	two	strains	following	infection	of	mice	via	inhalation.	However,	after	analysing	the	bacterial	loads	of	lung,	spleen,	and	kidney	tissue	at	various	time	points,	it	became	evident	that	the	BaTdp	KO	strain	was	able	to	colonise	lung	tissue	at	a	faster	rate	than	the	WT	strain.	Both	at	72	and	96	hours	post-infection,	animals	infected	with	the	BaTdp	KO	strain	displayed	significantly	higher	bacterial	loads	in	the	lungs	than	those	infected	with	the	WT	strain,	although	at	later	time	points	there	were	no	noticeable	differences.	We	do	not	yet	know	if	this	is	functionally	relevant,	but	taken	together,	the	data	suggests	that	BaTdp	is	not	a	major	virulence	factor.	Although	the	results	presented	in	chapter	4	indicated	that	BaTdp	was	able	to	form	TIR-TIR	interactions	with	mammalian	TLR	adaptor	proteins	in	vitro,	we	found	no	indication	of	the	protein	suppressing	TLR-mediated	immune	activation	when	expressed	in	mammalian	cells.	It	is	possible	that	the	interactions	are	simply	too	weak	to	be	functionally	relevant,	but	it	is	also	important	to	point	out	that	those	experiments	were	conducted	with	truncated	proteins	featuring	only	the	isolated	TIR	domains.	Although	it	is	unlikely	that	the	full	length	proteins	fold	in	a	manner	that	does	not	allow	for	complex	formation,	e.g.	by	not	exposing	the	relevant	interaction	sites,	we	cannot	rule	out	this	possibility	which	would	explain	why	BaTdp	did	not	appear	to	co-localise	with	MyD88	when	both	protein	
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were	overexpressed	in	the	same	cell.	The	complex	cellular	environment	may	also	contain	yet	to	be	discovered	factors	inhibiting	BaTdp	from	targeting	MyD88,	which	would	explain	why	we	only	observed	an	interaction	in	a	minimal	buffer	system.	Of	particular	interest	is	our	observation	that	BaTdp	appeared	to	be	targeting	cytoskeletal	networks	when	expressed	in	mammalian	cells.	A	similar	effect	had	previously	been	described	for	TcpB	(Radhakrishnan	et	al.,	2009),	although	TcpB	has	also	been	found	to	suppress	TLR-mediated	immune	activation	(Cirl	et	al.,	2008,	Sengupta	et	al.,	2010).	Here,	we	showed	that	HEK	cells	expressing	BaTdp	displayed	significantly	increased	cellular	levels	of	lipidated	LC3B,	indicative	of	increased	autophagy.		During	Western	blot	analysis,	the	amount	of	unlipidated	LC3B	detected	was	surprisingly	low.	This	assay	typically	results	in	bands	corresponding	to	LC3-I	and	LC3-II	of	similar	intensity,	although	results	where	the	band	for	unlipidated	LC3	was	barely	detectable	has	previously	been	described	during	starvation	of	HeLa	cells	(Tanida	et	al.,	2005).	In	that	case,	the	result	could	be	improved	with	the	addition	of	protease	inhibitors	E64d	and	pepstatin	A	in	the	growth	medium,	which	is	something	that	may	have	made	the	results	presented	here	more	clear.	We	do	not	know	exactly	why	this	phenomenon	occurs.	Inconsistent	cellular	extraction	of	LC3-I	and	–II	during	sample	preparation	is	unlikely,	as	the	lipidated	form	is	expected	to	be	less	soluble	than	the	unlipidated	form.	It	is	possible	that	the	antibody	used	for	detection	has	a	higher	affinity	for	lipidated	LC3B,	in	which	case	an	increased	amount	of	antibody	used	could	have	helped.	Regardless	of	the	reason,	results	presented	would	have	been	more	convincing	if	a	positive	control	
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sample,	such	as	analysis	of	cells	undergoing	starvation-induced	autophagy,	had	been	included	in	both	the	Western	blot	and	immunofluorescence	analyses.	It	is	known	that	mammalian	cell	exposure	to	B.	anthracis	lethal	toxin	(LT,	comprised	of	LF	and	PA)	results	in	an	increase	of	cellular	autophagy	(Tan	et	al.,	2009),	but	this	was	suggested	to	be	a	regular	host-defence	response	as	inhibition	of	autophagy	with	3-methyladenine	resulted	in	accelerated	cell	death	of	LT-treated	HL-60	cells.	On	the	other	hand,	Kandadi	and	colleagues	have	reported	that	TLR4	KO	mice	displayed	some	protection	against	LT	challenge	(Kandadi	et	al.,	2012).	They	proposed	that	this	effect	was	due	to	a	reduction	of	TLR4-induced	autophagy,	as	cardiomyocytes	display	autophagic	cell	death	during	heart	failure	(Knaapen	et	al.,	2001)	and	TLR4-activation	is	known	to	cause	autophagy	(Xu	et	al.,	2007).		As	discussed	in	section	1.4.2,	some	pathogenic	bacteria	are	also	known	to	subvert	host	autophagy	in	order	to	induce	a	niche	environment	suitable	for	intracellular	replication.	For	example,	S.	aureus	has	been	shown	to	enter	into	autophagosomes	shortly	after	cellular	infection	where	it	proceeds	to	replicate	(Schnaith	et	al.,	2007).	However,	B.	anthracis	has	so	far	not	been	described	to	engage	in	similar	mechanisms.	It	is	possible	that	B.	anthracis	induces	BaTdp-mediated	host	cell	autophagy	either	as	a	way	to	evade	host	immune	system,	or	to	amplify	the	toxic	effect	of	LT	on	cardiac	function	during	later	stages	of	infection.	However,	further	studies	are	warranted	to	support	a	definitive	conclusion	on	the	functional	relevance	of	this	protein.		 	
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Chapter	7		
Final	discussion	
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7.1	Recombinant	expression	of	TIR	domain	proteins	Generation	of	high	quality	proteins	by	recombinant	expression	and	purification	is	a	fundamental	part	of	functional	and	structural	protein	studies.	TIR	domain	proteins	have	consistently	been	demonstrated	to	be	difficult	to	produce	and	isolate,	leading	researchers	to	develop	various	strategies	to	improve	both	expression	yields	and	in	vitro	protein	stability,	such	as	the	use	of	solubility	enhancing	tags	(Rana	et	al.,	2011,	Snyder	et	al.,	2013,	Zou	et	al.,	2014).	Expression	of	truncated	proteins	featuring	only	the	TIR	domain	has	so	far	been	the	preferred	method	for	structural	studies	of	this	domain,	likely	due	to	low	expression	yields	when	attempting	to	express	full	length	TIR	domain-containing	proteins	in	bacterial	systems.	For	example,	Spear	and	colleagues	reported	that	they	were	unable	to	express	a	sufficient	amount	of	soluble	full	length	YpTdp,	leading	them	to	study	the	isolated	TIR	domain	instead	(Spear	et	al.,	2012).	This	was	also	the	case	in	this	study,	where	no	soluble	expression	of	full	length	SARM	protein	could	be	obtained.	A	problem	with	this	strategy	is	that	we	do	not	know	if	the	protein	domain	adopts	a	different	overall	fold	as	a	truncated	version,	or	if	certain	parts	of	the	domain	that	are	not	exposed	in	the	full	length	protein	interfered	with	functional	assays.		Another	important	tool	for	the	improvement	of	recombinant	expression	is	to	design	fusion	proteins	by	connecting	the	target	protein	with	a	protein	tag.	In	this	study,	expressing	TIR	domain	proteins	as	fusion	proteins	with	GST-	or	GB1-tags	dramatically	improved	both	expression	yields	and	solubility.	However,	an	unavoidable	problem	with	this	strategy	is	that	the	tag	may	interfere	with	both	the	protein	folding	and	downstream	functional	assays.	A	commonly	observed	problem	is	also	the	formation	of	so-called	soluble	aggregates,	where	the	target	
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protein	is	misfolded,	but	remains	in	solution	due	to	the	large	solubility	tag	it	is	attached	to.		In	our	experience,	these	issues	are	difficult	to	overcome	with	TIR	domain	proteins,	and	instead	of	attempting	to	circumvent	them,	focus	on	quality	control	remained	the	key	concern.	The	final	product	needs	to	be	pure,	homogenous	and	most	importantly	active.	The	GEV2	vector	(Huth	et	al.,	1997),	coding	for	a	target	protein	N-terminally	fused	with	a	GB1-tag	and	C-terminally	with	a	His-tag,	in	particular	was	useful	for	generation	of	SARM-TIR,	YpTIR,	BaTIR	and	MyD88-TIR	protein	by	bacterial	expression.	High	purity	soluble	protein	could	typically	be	isolated	following	IMAC	and	SEC	purification,	and	this	system	may	be	suitable	as	a	generic	platform	for	recombinant	expression	and	purification	of	TIR	domains.			
7.2	Functional	role	of	SARM	Of	the	human	TIR	domain	proteins,	SARM	is	functionally	and	evolutionarily	unique.	Phylogenetic	analysis	of	the	human	SARM	amino	acid	sequence	indicated	that	the	protein	is	more	closely	related	to	bacterial	TIR	domain	proteins	than	mammalian	ones.	Functional	SARM	homologs	have	been	identified	in	a	wide	range	of	organisms,	including	invertebrate	species	such	as	the	horseshoe	crab	(Belinda	et	al.,	2008)	and	C.	elegans	(Couillault	et	al.,	2004).	SARM	displays	the	highest	degree	of	evolutionary	conservation	of	all	human	TIR	domain	proteins,	and	interestingly,	it	also	appears	to	be	the	most	dissimilar	on	a	functional	level.	While	it	is	well	established	that	the	TLRs	recognise	various	PAMPs	in	order	to	trigger	the	innate	immune	response,	and	that	cytosolic	TLR	adaptor	proteins	MyD88,	MAL,	TRIF	and	TRAM	mediate	immune	signalling	
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downstream	of	the	receptors,	the	functional	role	of	SARM	is	still	not	fully	understood.		Multiple	studies	have	indicated	that	SARM	has	an	anti-inflammatory	role,	acting	by	inhibiting	TLR3-	and	TLR4-activation	(Peng	et	al.,	2010,	Carty	et	al.,	2006).	However,	SARM-deficient	mice	displayed	significantly	lower	expression	of	pro-inflammatory	cytokine	TNFα	following	infection	with	West	Nile	virus	(WNV)	(Szretter	et	al.,	2009).	A	study	by	Kim	and	colleagues	also	demonstrated	that	both	mouse	and	human	myeloid	cells	express	little	to	no	SARM	(Kim	et	al.,	2007b),	which	is	inconsistent	with	the	idea	of	SARM	playing	a	dominant	role	in	innate	immune	regulation.	Recent	studies	have	also	indicated	that	SARM	plays	a	central	role	in	mediating	axonal	degeneration	(Osterloh	et	al.,	2012,	Gerdts	et	al.,	2013,	Gerdts	et	al.,	2015),	demonstrating	that	it	is	a	multifaceted	protein	with	possible	involvement	in	several	biological	processes.	The	data	generated	in	this	study	further	confirms	SARM’s	ability	to	act	as	an	immunosuppressive	protein.	SARM	expression	resulted	in	a	significant	reduction	of	the	secretion	of	multiple	proinflammatory	cytokines	in	HEK	cells	following	both	TLR2-	and	TLR4-mediated	immune	activation.	This	suggests	that	SARM	not	only	acts	on	the	TRIF-dependent	pathway	as	previously	demonstrated	(Carty	et	al.,	2006),	but	also	has	the	ability	to	act	on	the	MyD88-dependent	pathway.	Furthermore	the	research	also	showed	that	the	SARM	TIR-domain	binds	directly	to	the	MyD88	TIR	domain.	Both	binding	to	MyD88	and	the	immunosuppressive	effects	are	dependent	on	G601	in	the	SARM	BB-loop,	strongly	suggesting	that	this	motif	is	functionally	important.				
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7.3	Functional	role	of	BaTdp	It	is	now	well	established	that	TIR	domain	proteins	are	common	among	bacterial	species.	In	the	bioinformatics	study	conducted	here,	more	than	3000	TIR-	or	TIR-like	proteins	of	bacterial	origin	were	identified,	comprising	almost	one	third	of	all	proteins	in	these	families.	However,	the	exact	purpose	of	these	proteins	is	still	not	well	understood.	Some	bacterial	TIR	proteins,	such	as	the	
Brucella	encoded	TcpB	and	uropathogenic	E.	coli	encoded	TcpC	have	been	demonstrated	to	regulate	host	cell	immunity	by	suppressing	TLR	signalling	in	human	cells	(Cirl	et	al.,	2008).	However,	in	this	study	we	did	not	find	any	convincing	evidence	that	the	B.	anthracis	encoded	BaTdp	plays	a	major	role	in	host	immune	suppression,	or	overall	virulence.		Despite	the	protein	associating	with	multiple	human	TLR	adaptor	proteins	in	vitro,	BaTdp	expression	in	human	cell	lines	did	not	affect	the	cellular	activation	of	proinflammatory	cytokines	following	PAMP	stimulation.	BaTdp	also	did	not	appear	to	target	MyD88	when	overexpressed	in	HEK	cells,	but	rather	co-localised	with	microtubule	structures.	It	is	not	clear	why	full	length	BaTdp	would	not	bind	to	cytosolic	MyD88	in	the	cell	based	assays,	but	it	should	be	pointed	out	that	some	fundamental	differences	between	the	interaction	experiments	exist.	For	example,	as	the	GST	pull	down	studies	was	performed	with	truncated	versions	of	BaTdp	comprising	just	the	TIR	domain,	a	possible,	but	unlikely,	explanation	could	be	that	the	full	length	protein	folds	in	a	way	that	blocks	TIR-TIR	interactions.	The	pull	down	assay	also	does	not	provide	any	information	regarding	the	affinity	of	interactions,	and	results	should	therefore	be	used	with	caution.	
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Further	investigation	showed	that	BaTdp	expression	in	mammalian	cells	resulted	in	a	significant	increase	of	cellular	autophagy	activity.	While	autophagy	is	considered	a	host	defence	mechanism,	several	pathogenic	bacteria	have	been	described	to	exploit	this	process	in	order	to	facilitate	intracellular	replication	(Campoy	and	Colombo,	2009).	However,	to	date	there	is	no	evidence	of	B.	
anthracis	utilising	autophagy	for	this	purpose.	Although	our	findings	in	this	thesis	work	are	novel,	further	studies	are	needed	before	any	firm	conclusion	on	the	functional	relevance	of	this	effect	may	be	drawn.		
7.4	Therapeutic	targeting	of	TLRs	and	TLR	adaptor	proteins	Given	their	central	role	in	immune	activation,	it	is	not	surprising	that	the	TLRs	have	attracted	attention	as	potential	therapeutic	targets	(O'Neill,	2003,	Hennessy	et	al.,	2010,	Cook	et	al.,	2004).	One	of	the	main	functions	of	TLRs	is	to	induce	cytokine	expression,	which	is	linked	to	a	wide	range	of	inflammatory	conditions,	and	TLR	antagonists	have	been	proposed	as	viable	strategies	for	treatment	of	both	acute	and	chronic	inflammatory	diseases.	The	most	effective	treatment	for	chronic	inflammation	currently	available	revolves	around	blocking	certain	cytokines	with	monoclonal	antibodies	or	antibody-like	molecules.	However,	one	could	argue	that	as	the	TLRs	appear	earlier	in	the	signalling	cascade,	targeting	these	molecules	may	comprise	a	more	potent	therapeutic	strategy.		Drugs	targeting	TLR4	have	been	tested	in	clinical	settings	for	treatment	of	sepsis,	examples	include	Eritoran,	a	synthetic	LPS	analogue	that	targets	the	ECD	domain	of	TLR4	(Kim	et	al.,	2007a),	and	Resatorvid,	a	small	molecule	drug	that	targets	the	TLR4	TIR	domain	(Takashima	et	al.,	2009).	Although	both	drugs	
	 211	
showed	high	potential	in	in	vitro	and	early	phase	clinical	trials,	results	from	phase	2	or	3	trials	were	not	convincing	and	developments	of	both	drugs	were	suspended.	One	possible	explanation	for	the	drugs	inability	to	perform	in	a	clinical	setting	is	that	a	great	deal	of	redundancy	is	built	into	the	innate	immune	system.	Targeting	a	single	TLR	may	not	be	sufficient	for	treatment	of	infection-related	inflammatory	diseases,	as	the	pathogen	would	still	be	recognised	by	other	TLRs.	For	example,	gram-negative	bacteria	may	be	recognised	by	not	only	TLR4	(LPS),	but	also	TLR2	(lipoprotein),	TLR5	(flagellin)	TLR7	(RNA)	and	TLR9	(DNA).	Nevertheless,	a	monoclonal	anti-TLR4	antibody,	NI-0101,	is	currently	in	development	by	Novimmune	for	treatment	of	chronic	inflammation.	The	antibody	was	well	tolerated	during	the	phase	1	clinical	trial,	and	we	eagerly	await	the	results	from	subsequent	trials.		An	alternative	approach	to	targeting	the	actual	TLR	may	be	to	target	one	or	multiple	downstream	signalling	molecules.	All	human	TLRs	except	TLR3	couple	via	MyD88	to	induce	immune	activation,	suggesting	that	this	molecule	may	pose	an	attractive	target	for	modulation	of	immune	activation.	A	study	by	Isnardi	and	colleagues	concluded	that	while	MyD88-deficient	patients	showed	defects	in	establishing	B-cell	tolerance,	they	did	not	develop	any	autoimmune	diseases,	suggesting	that	blocking	TLR	signalling	likely	thwarts	development	of	autoimmunity	(Isnardi	et	al.,	2008).		An	immediate	problem	with	this	strategy	is	that	unlike	cytokines,	the	TLR	adaptors	such	as	MyD88	are	not	secreted	from	immune	cells,	hence	any	drug	targeting	these	proteins	would	need	to	cross	the	cellular	membrane.	Monoclonal	antibody	therapy	therefore	does	not	appear	to	be	a	viable	strategy	in	this	case.		
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Decoy	peptides	based	on	certain	structural	motifs	from	multiple	TIR	domain	proteins	have	recently	been	suggested	as	potential	therapeutics	based	on	their	ability	to	prevent	TIR-TIR	interactions.	By	fusing	these	peptides	to	cell	penetrating	peptide	sequences,	they	can	easily	be	internalised	by	cells	and	exposed	to	the	cytosolic	environment.	Toshchakov	and	colleagues	have	successfully	used	this	strategy	to	design	multiple	peptides	based	on	sequences	from	both	TLRs	(Toshchakov	et	al.,	2007)	and	TLR	adaptor	proteins	(Toshchakov	et	al.,	2005),	many	of	which	were	found	to	suppress	TLR	mediated	immune	activation	in	cellular	experiments.	A	small	molecule	designed	to	mimic	the	(F/Y)-(V/L/I)-(P/G)	consensus	sequence	in	the	BB	loops	of	multiple	TIR	domain	proteins	has	also	been	demonstrated	to	interfere	with	the	association	between	MyD88	and	IL1-R,	but	not	with	the	MyD88/TLR4	interaction	(Bartfai	et	al.,	2003).		In	this	study,	we	designed	a	peptide	based	on	the	SARM	BB-loop	motif	fused	with	the	cell	penetrating	Antennapedia	homeodomain	sequence.	The	peptide	could	be	found	in	the	cytosol	of	HEK	cells	after	just	30	minutes	of	treatment,	indicating	that	it	crosses	the	cellular	membrane	without	difficulty.	However,	despite	in	vitro	data	indicating	that	the	peptide	targets	MyD88,	only	a	minor	reduction	of	IL-8	activation	following	PAMP	stimulation	could	be	seen	in	cells	that	had	been	pre-treated	with	up	to	20	µM	of	the	peptide.	The	rationale	for	basing	the	peptide	on	the	SARM	BB-loop	motif	was	that	a	point	mutation	in	this	region	rendered	the	protein	unable	to	associate	with	both	MyD88	and	TRIF,	but	we	do	not	know	if	this	is	the	actual	binding	site,	or	what	parts	of	MyD88	and	TRIF	that	are	targeted.	While	this	platform	for	delivery	of	drugs	targeting	
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intracellular	proteins	appears	promising,	further	optimisation	of	the	SARM	sequence	is	required.		
7.5	Future	perspectives	In	order	to	further	advance	our	understanding	of	TIR	protein	dynamics	and	the	therapeutic	potential	of	targeting	TLR	pathways,	it	is	imperative	to	elucidate	the	interaction	profiles	of	TIR	domain	proteins	on	a	molecular	level.	With	regard	to	SARM,	a	bottleneck	in	this	study	has	been	that	we	do	not	know	the	molecular	structure	of	the	protein’s	TIR	domain.	We	have	assumed	that	the	SARM	TIR	domain	adopts	a	similar	overall	fold	as	the	TIR	domains	of	previously	solved	structures,	but	a	high-resolution	crystal	structure	of	the	SARM	TIR	domain	would	significantly	facilitate	further	studies.	In	this	study,	we	have	attempted	to	crystallise	the	SARM	TIR	domain,	but	were	unable	to	obtain	any	diffracting	protein	crystals	(data	not	shown).	Given	that	SARM	was	found	to	interact	with	several	TIR	adaptor	proteins,	it	is	possible	that	the	domain	can	be	stabilised	by	co-expression	and	co-crystallisation	with	another	TIR	protein,	such	as	MyD88,	which	could	form	the	basis	for	further	experiments	in	this	area.	To	support	further	development	of	SARM-derived	peptides	with	therapeutic	potential,	it	is	important	to	develop	a	better	understanding	of	mechanisms	that	are	used	for	SARM	association	with	other	TIR	proteins.	In	particular,	elucidation	of	the	binding	interface	between	SARM	and	MyD88	would	be	of	interest,	as	MyD88	is	the	key	adaptor	protein	downstream	of	the	TLRs.	HDXMS	and	2D-NMR	methodology	are	well	suited	techniques	for	this	application,	but	further	optimisation	of	the	experimental	conditions	are	required.	
	 214	
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